|
Gaucher disease, type 3
|
|
Norrbottnian Gaucher disease; Subacute Neuronopathic Gaucher Disease; Type 3 Gaucher Disease
|
Gaucher disease, type 3 Clinical Trials
- A Study of the Efficacy and Safety of Genz-112638 in Type 1 Gaucher Patients
ClinicalTrials.gov Identifier: NCT00358150 - Active, not recruiting
Gaucher Disease, Type 1; Cerebroside Lipidosis Syndrome; Glucocerebrosidase Deficiency Disease; Glucosylceramide Beta-Glucosidase Deficiency Disease; Gaucher Disease, Non-Neuronopathic Form
- Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Disease
ClinicalTrials.gov Identifier: NCT00364858 - Active, not recruiting
Gaucher Disease, Type 1; Cerebroside Lipidosis Syndrome; Glucocerebrosidase Deficiency Disease; Glucosylceramide Beta-Glucosidase Deficiency Disease; Gaucher Disease, Non-Neuronopathic Form
- Open-Label Extension Study Evaluating Long Term Safety in Patients With Type 1 Gaucher Disease Receiving DRX008A (ERT)
ClinicalTrials.gov Identifier: NCT00391625 - Active, not recruiting
Gaucher Disease, Type 1
- Safety Study of AT2101 in Adult Patients With Type 1 Gaucher Disease Currently Receiving Enzyme Replacement Therapy
ClinicalTrials.gov Identifier: NCT00433147 - Recruiting
Gaucher Disease, Type 1
- Multicenter Open-Label Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase
ClinicalTrials.gov Identifier: NCT00478647 - Recruiting
Gaucher Disease, Type 1
- Oral Miglustat in Adult Patients With Stable Type 1 Gaucher Disease
ClinicalTrials.gov Identifier: NCT00319046 - Recruiting
Type 1 Gaucher Disease
- A Multicenter Study of the Efficacy of Cerezyme in Testing Skeletal Disease in Patients With Type I Gaucher Disease.
ClinicalTrials.gov Identifier: NCT00365131 - Completed
Gaucher Disease Type I; Cerebroside Lipidosis Syndrome; Clucocerebrosidase Deficiency Disease; Glucosylceramide Beta-Glucosidase Deficiency Disease; Gaucher Disease, Non-Neuronopathic Form
- A Multicenter, Randomized, Double-Blind, Parallel-Group Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) ERT Compared With Imiglucerase in Type I Gaucher Disease
ClinicalTrials.gov Identifier: NCT00553631 - Not yet recruiting
Gaucher Disease, Type 1
- A Study of GA-GCB Enzyme Replacement Therapy in Gaucher Disease
ClinicalTrials.gov Identifier: NCT00430625 - Recruiting
Gaucher Disease,Type 1
- A Study of AT2101 in Patients With Gaucher Disease
ClinicalTrials.gov Identifier: NCT00446550 - Recruiting
Gaucher Disease, Type 1
- International Collaborative Gaucher Group (ICGG) Gaucher Registry
ClinicalTrials.gov Identifier: NCT00358943 - Recruiting
Gaucher Disease; Cerebroside Lipidosis Syndrome; Glucocerebrosidase Deficiency Disease; Glucosylceramide Beta-Glucosidase Deficiency Disease
- Convection-Enhanced Delivery of Glucocerebrosidase to Treat Type 2 Gaucher Disease
ClinicalTrials.gov Identifier: NCT00244582 - Completed
Type 2 Gaucher Disease
- OGT 918-006: A Phase I/II Randomized, Controlled Study of OGT 918 in Patients with Neuronopathic Gaucher Disease
ClinicalTrials.gov Identifier: NCT00041535 - Active, not recruiting
Gaucher Disease
- A Study to Evaluate and Characterize the Effect of Pharmacological Chemicals on Blood From Patients With Gaucher Disease
ClinicalTrials.gov Identifier: NCT00465062 - Recruiting
Gaucher Disease
- A Phase III Trial to Assess the Safety and Efficacy of Plant Cell Expressed GCD in Patients With Gaucher Disease
ClinicalTrials.gov Identifier: NCT00376168 - Recruiting
Gaucher Disease
- Nervous System Degeneration in Glycosphingolipid Storage Disorders
ClinicalTrials.gov Identifier: NCT00029965 - Recruiting
Gangliosidoses; Gaucher Disease
- Positron Emission Tomography (PET) Imaging in People With Gaucher Mutations
ClinicalTrials.gov Identifier: NCT00302146 - Recruiting
Glucocerebrosidase Mutations; Gaucher Disease
- Study to Evaluate Blood Cell Lines From Patients With Gaucher Disease
ClinicalTrials.gov Identifier: NCT00351156 - Completed
Gaucher Disease
- Study on the Prognosis and Effect of Anti-Diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery Disease
ClinicalTrials.gov Identifier: NCT00513630 - Active, not recruiting
Type 2 Diabetes; Coronary Artery Disease
- Phase II Study of Glucocerebrosidase in Patients With Gaucher Disease
ClinicalTrials.gov Identifier: NCT00004293 - Recruiting
Gaucher's Disease
- Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Efficacy and Pharmacokinetics of Myozyme in Patients with Late-Onset Pompe Disease.
ClinicalTrials.gov Identifier: NCT00158600 - Active, not recruiting
Pompe Disease (Late-onset); Glycogen storage disease type II (GSD-II); Acid Maltase Deficiency Disease; Glycogenosis 2
- Markers and Mechanisms of Vascular Disease in Type II Diabetes
ClinicalTrials.gov Identifier: NCT00256646 - Active, not recruiting
Type 2 Diabetes Mellitus
- Blood Pressure and Glucose Lowering for the Prevention of Vascular Disease in High Risk Patients with Type 2 Diabetes.
ClinicalTrials.gov Identifier: NCT00145925 - Active, not recruiting
Diabetes Mellitus, Type 2
- Post-Marketing Safety Study of GSK Biological''s Pediarix™ Vaccine.
ClinicalTrials.gov Identifier: NCT00146835 - Active, not recruiting
Prophylaxis: Diphtheria, tetanus, pertussis, hepatitis B, poliovirus type 1, type 2 and type 3
- Efficacy and Safety In Poorly Controlled Type 2 Diabetics
ClinicalTrials.gov Identifier: NCT00044460 - Active, not recruiting
type 2 diabetes
- Japanese Primary prevention of atherosclerosis with Aspirin for Diabetes (JPAD) Trial
ClinicalTrials.gov Identifier: NCT00110448 - Active, not recruiting
Coronary Disease; Arteriosclerosis; Diabetes Mellitus, Type 2
- Sulodexide to Treat Type 2 Diabetic Nephropathy
ClinicalTrials.gov Identifier: NCT00342238 - Recruiting
Overt Type 2 Diabetic Nephropathy; Chronic Kidney Disease; Diabetes Type 2
- Miglustat in Niemann-Pick Type C Disease
ClinicalTrials.gov Identifier: NCT00517153 - Active, not recruiting
Niemann-Pick Type C Disease
- An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes
ClinicalTrials.gov Identifier: NCT00229658 - Active, not recruiting
Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus
- Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints
ClinicalTrials.gov Identifier: NCT00549757 - Recruiting
Type 2 Diabetes Mellitus; Cardiovascular Disease
- Evaluation of ALT-2074 in Subjects With Type-2 Diabetes, Haptoglobin Type 2-2 Genotype and Coronary Artery Disease
ClinicalTrials.gov Identifier: NCT00491543 - Recruiting
Diabetes; Coronary Artery Disease
- Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients with Mild to Moderate Alzheimer's Disease (AD)
ClinicalTrials.gov Identifier: NCT00104273 - Active, not recruiting
Dementia, Alzheimer Type
- Effects of a Mediterranean Style Diet on Vascular Health in Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00163683 - Recruiting
Type 2 Diabetes; Coronary Heart Disease
- Effect of Nuts vs. a Wheat Bran Muffin in Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00410722 - Recruiting
Type 2 Diabetes; Cardiovascular Disease; Diet Therapy
- Long-Term Study of Safety and Efficacy of WelChol® as an Additional Therapy in Patients with Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00151762 - Active, not recruiting
Type 2 Diabetes
- Islet Transplantation in Type 1 Diabetics Using the Edmonton Protocol of Steroid Free Immunosuppression
ClinicalTrials.gov Identifier: NCT00133809 - Active, not recruiting
Diabetes Mellitus, Type 1
- Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines, Each Administered at 2, 4, 6, and 12 to 15 Months of Age.
ClinicalTrials.gov Identifier: NCT00134719 - Active, not recruiting
Invasive bacterial disease caused by Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y.
- PEG-Glucocerebrosidase for the Treatment of Gaucher Disease
ClinicalTrials.gov Identifier: NCT00001410 - Completed
Gaucher's Disease
- Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00308737 - Active, not recruiting
Diabetes Mellitus, Type I; Diabetes Mellitus, Type II
- A Study to Evaluate the Effects of Pharmacological Chaperones in Cells From Patients With Pompe Disease
ClinicalTrials.gov Identifier: NCT00515398 - Recruiting
Pompe Disease; Glycogen Storage Disease Type II
- Olmesartan Medoxomil in Diabetes Mellitus
ClinicalTrials.gov Identifier: NCT00185159 - Active, not recruiting
Diabetes Mellitus, Type 2; Cardiovascular Disease; Kidney Disease
- Efficacy of Alphanate FVIII/VWF Concentrate in Type 3 Von Willebrand Patients
ClinicalTrials.gov Identifier: NCT00555555 - Recruiting
Congenital Type 3 Von Willebrand Disease
- Late-Onset Treatment Study Extension Protocol
ClinicalTrials.gov Identifier: NCT00455195 - Active, not recruiting
Pompe Disease (Late-Onset); Glycogen Storage Disease Type II (GSD-II); Glycogenesis 2; Acid Maltase Deficiency
- TRx0014 in Patients With Mild or Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00515333 - Active, not recruiting
Dementia, Alzheimer Type
- A Single-Blind, Placebo-Controlled, Dose-Ranging Trial of Oral HDV-Insulin in Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov Identifier: NCT00521378 - Active, not recruiting
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2
- Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)
ClinicalTrials.gov Identifier: NCT00032487 - Active, not recruiting
Type 2 diabetes mellitus
- ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial
ClinicalTrials.gov Identifier: NCT00141453 - Active, not recruiting
Diabetic Nephropathy; type 2 diabeted mellitus; Proteinuria
- Effects of Vitamin B1 in Type 1 Diabetic Patients
ClinicalTrials.gov Identifier: NCT00117026 - Active, not recruiting
Diabetes Mellitus, Type 1
- Pompe Disease Registry
ClinicalTrials.gov Identifier: NCT00231400 - Recruiting
Glycogen Storage Disease Type II; Pompe Disease
- Study In People With Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00196989 - Active, not recruiting
Type 2 Diabetes Mellitus
- Effect of Metformin in Patients with Type-1 Diabetes with Inadequate Glycaemic Control by Insulin and Diet
ClinicalTrials.gov Identifier: NCT00118937 - Active, not recruiting
Diabetes Mellitus, Type 1
- Botulinum Toxin Type A (BOTOX) in the Management of Levodopa-Induced Peak-Dose Dyskinesias in Parkinson's Disease
ClinicalTrials.gov Identifier: NCT00477802 - Recruiting
Parkinson Disease
- Phase I Study of Retrovirally Mediated Transfer of the Human Glucocerebrosidase Gene into Peripheral Blood Stem Cells for Autologous Transplantation in Patients with Type I Gaucher Disease
ClinicalTrials.gov Identifier: NCT00004294 - Completed
Gaucher's Disease
- Dietary Interventions in Type 2 Obese Diabetic Patients in the Community
ClinicalTrials.gov Identifier: NCT00520182 - Active, not recruiting
Diabetes Type 2
- Influence of Physical Training on Mitochondrial Function in Type 2 Diabetic Patients
ClinicalTrials.gov Identifier: NCT00365495 - Active, not recruiting
Type 2 Diabetes
- A Study in Type 1 Diabetic Patients With Repeated Doses of E1 in Combination With G1
ClinicalTrials.gov Identifier: NCT00239148 - Active, not recruiting
Type 1 Diabetes
- A Study in Type 2 Diabetic Patients With Repeated Doses of E1 in Combination With G1
ClinicalTrials.gov Identifier: NCT00239187 - Active, not recruiting
Type 2 Diabetes
- Open Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide
ClinicalTrials.gov Identifier: NCT00334503 - Active, not recruiting
Type 2 Diabetes Mellitus
- 4 Weeks Treatment of Type II Diabetic Patients With BI 44847
ClinicalTrials.gov Identifier: NCT00558909 - Active, not recruiting
Diabetes Mellitus, Type 2
- Surgical Treatment of Non-Obese Type 2 Diabetic Patients With Duodenal Exclusion
ClinicalTrials.gov Identifier: NCT00566358 - Active, not recruiting
Diabetes Mellitus, Type 2
- Double-Blind Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide
ClinicalTrials.gov Identifier: NCT00334399 - Active, not recruiting
Type 2 Diabetes Mellitus
- Safety and Efficacy of PEG-Encapsulated Islet Allografts Implanted in Type I Diabetic Recipients
ClinicalTrials.gov Identifier: NCT00260234 - Active, not recruiting
Diabetes Mellitus, Type 1
- Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression
ClinicalTrials.gov Identifier: NCT00566813 - Active, not recruiting
Diabetes Mellitus, Type 1
- Family Management of Type 1 Diabetes in Children
ClinicalTrials.gov Identifier: NCT00273286 - Active, not recruiting
Diabetes Mellitus, Type 1
- Sitagliptin vs Glipizide in Patients With Type 2 Diabetes Mellitus and End-Stage Renal Disease
ClinicalTrials.gov Identifier: NCT00509236 - Recruiting
Type 2 Diabetes Mellitus; Renal Disease, End-Stage
- Phase I Single Dose-Escalation Safety Study of Human Glucocerebrosidase (prGCD)
ClinicalTrials.gov Identifier: NCT00258778 - Completed
Gaucher Disease
- Lifestyle Intervention in a General Population for Prevention of Ischaemic Heart Disease
ClinicalTrials.gov Identifier: NCT00289237 - Active, not recruiting
CHD; AMI; CVD; Type 2 Diabetes; COLD
- A 2 Year Random Control Trial of Patients with Type 2 Diabetes Focusing on Cardiovascular Diagnostics and Metabolic Control
ClinicalTrials.gov Identifier: NCT00133718 - Active, not recruiting
Diabetes Mellitus; Type 2 Diabetes Mellitus
- Effect of Repaglinide Versus Metformin Treatment in Non-Obese Patients With Type-2-Diabetes
ClinicalTrials.gov Identifier: NCT00118963 - Active, not recruiting
Diabetes Mellitus, Type 2
- Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C
ClinicalTrials.gov Identifier: NCT00344331 - Recruiting
Neimann-Pick Disease
- Efficacy and Safety of Vildagliptin in Patients with Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00102388 - Active, not recruiting
Diabetes Mellitus, Type 2
- Efficacy and Safety of Vildagliptin in Patients with Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00106340 - Active, not recruiting
Diabetes Mellitus, Type 2
- New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial
ClinicalTrials.gov Identifier: NCT00100178 - Active, not recruiting
Diabetes Mellitus, Type 1
- Prevalence of Macrovascular Disease in Type 2 Diabetes Mellitus
ClinicalTrials.gov Identifier: NCT00298844 - Recruiting
Type 2 Diabetes Mellitus
- Diet, Obesity and Genes (DiOGenes)
ClinicalTrials.gov Identifier: NCT00390637 - Active, not recruiting
Obesity; Metabolic Syndrome; Type 2 Diabetes; Cardiovascular Disease
- Long-term Study of Starlix+Diovan to Delay Type II Diabetes Mellitus
ClinicalTrials.gov Identifier: NCT00097786 - Active, not recruiting
Diabetes Mellitus, Type 2
- Insulin NovoRapid Vs. Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose
ClinicalTrials.gov Identifier: NCT00145353 - Active, not recruiting
Type 1 diabetes mellitus
- Pilot Study of B-Type Natrieutic Peptide (BNP) Levels in Patients With Congenital Heart Disease(BNP)
ClinicalTrials.gov Identifier: NCT00308230 - Recruiting
Congenital Heart Disease; Cardiovascular Disease
- A Randomized, Controlled Study on Ca Blocker Vs. AII Antagonists in Hypertension with Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00144144 - Active, not recruiting
Hypertension; Diabetes Mellitus, Type 2
- The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00279201 - Active, not recruiting
Diabetes Mellitus, Type 2
- Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Type 1 Diabetes
ClinicalTrials.gov Identifier: NCT00447382 - Active, not recruiting
Diabetes Mellitus, Type 1
- Effect of Long Term α-Lipoic Acid Treatment on Endothelial Function in Patients With Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00490867 - Active, not recruiting
Type 2 Diabetes
- Outcomes and Cost Consequences of Using an Internet Co-Management Module to Improve the Quality of Type 1 Diabetes Care
ClinicalTrials.gov Identifier: NCT00194558 - Active, not recruiting
Diabetes Mellitus, Type 1
- Study of Weight Loss Using Gastric Stimulation in Obese Patients With Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00200018 - Active, not recruiting
Severe to Morbid Obesity and Type 2 Diabetes
- Placebo-Controlled Study of the Combination of SYR-322 and Pioglitazone HCl in the Treatment of Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00328627 - Active, not recruiting
Type 2 Diabetes Mellitus
- Efficacy of Vildagliptin 100 MG as Compared to Placebo as Add-on to Metformin in Patients With Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00351884 - Active, not recruiting
Diabetes Mellitus, Type 2
- Effect of Liraglutide in Combination With Sulfonylurea (SU) on Blood Glucose Control in Subjects With Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00395746 - Active, not recruiting
Diabetes Mellitus, Type 2
- Natural History Study of Plexiform Neurofibromas in Patients With Neurofibromatosis Type 1
ClinicalTrials.gov Identifier: NCT00445991 - Active, not recruiting
Neurofibromatosis Type 1 (nf1); Precancerous/Nonmalignant Condition
- Safety and Efficacy of Inhaled Pre-Prandial Human Insulin in Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00343980 - Active, not recruiting
Diabetes Mellitus, Type 2
- Randomized Study of Real-Time Continuous Glucose Monitors in the Management of Type 1 Diabetes
ClinicalTrials.gov Identifier: NCT00406133 - Active, not recruiting
Type 1 Diabetes
- Impact of Self-Monitoring Blood Glucose Frequency on Glycemic Control in Patients With Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00202033 - Active, not recruiting
Type 2 Diabetes
- A Study Assessing Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise
ClinicalTrials.gov Identifier: NCT00374907 - Active, not recruiting
Type 2 Diabetes
- Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00376038 - Active, not recruiting
Type 2 Diabetes Mellitus
- Long Term Safety of Vildagliptin (100mg qd) In Patients With Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00389415 - Active, not recruiting
Diabetes Mellitus, Type 2
- A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
ClinicalTrials.gov Identifier: NCT00460941 - Active, not recruiting
Diabetes Mellitus, Type 2
- Effect of Real Time Continuous Glucose Monitoring System on the Management of Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00536549 - Active, not recruiting
Type 2 Diabetes
- Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH
ClinicalTrials.gov Identifier: NCT00564018 - Enrolling by invitation
Type 1 Diabetes
- Efficacy and Safety of Vildagliptin Compared to Placebo on the Incretin Effect in Patients With Type 2 Diabetes Treated With Metformin
ClinicalTrials.gov Identifier: NCT00396071 - Active, not recruiting
Diabetes Mellitus, Type 2
- Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00518882 - Active, not recruiting
Type 2 Diabetes Mellitus
- A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00330473 - Active, not recruiting
Type 2 Diabetes Mellitus
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
